Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
RhinoSystems
AddedFeb 16, 2024
UpdatedJun 18, 2026
RhinoSystems

RhinoSystems

Naväge Nasal Care: A unique, mess-free saline nasal irrigator for effective sinus relief and reduced medication dependence.

HQ
Brooklyn, OH, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to provide effective and natural sinus relief, RhinoSystems developed the Naväge Nasal Care device. This innovative product is the world's only powered saline nasal irrigator designed to alleviate sinus congestion caused by allergies, sinus issues, and environmental pollutants. Naväge aims to reduce dependence on medications and minimize antibiotic resistance through regular nasal irrigation. The company's core vision is to promote better respiratory health and improve the quality of life for individuals suffering from nasal and sinus conditions.

RhinoSystems has garnered attention and support from notable healthcare professionals and investors who recognize the importance of non-pharmaceutical treatments for sinus relief. The Naväge Nasal Care device has achieved significant market penetration, becoming a trusted solution for many users seeking natural and effective sinus care. Its impact is evident in the reduction of medication usage among its users and the promotion of overall nasal hygiene. Through its innovative approach, RhinoSystems continues to make a meaningful difference in respiratory health management.

RhinoSystems - Similar Companies

Nasus Medical logo

Nasus Medical

nasusmedical.com

Nasopure logo

Nasopure

nasopure.com

Excelent logo

Excelent

Aerin Medical logo

Aerin Medical

Navio Systems logo

Navio Systems

navio.com

Navv Systems logo

Navv Systems

Hale logo

Hale

Airware Labs logo

Airware Labs

airwarelabs.com

Endoclear logo

Endoclear

Perceptive Navigation logo

Perceptive Navigation

NavisHealth logo

NavisHealth

Respirix logo

Respirix

SoundHealth logo

SoundHealth

soundhealth.life

Navimize logo

Navimize

navimize.com

FreeNav logo

FreeNav

free-nav.com

RhinoSystems - Quick Facts

Who are RhinoSystems' competitors?

Companies similar to RhinoSystems include Nasus Medical, Nasopure, Excelent and Aerin Medical.

When was RhinoSystems founded?

RhinoSystems was founded in 2007.

Where is RhinoSystems' headquarters located?

RhinoSystems' headquarters is located in Brooklyn, OH, US.

When was RhinoSystems' last funding round?

RhinoSystems' most recent funding round was for $1M (USD) in September 2014.

How much has RhinoSystems raised to-date?

As of Sep 15, 2014, RhinoSystems has raised a total of $1M (USD).

How many employees does RhinoSystems have?

RhinoSystems has 125 employees as of Feb 4, 2024.

RhinoSystems - Classification

Industry
  • Hardware
Ownership
  • Private
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities